Edison, NJ, United States of America

Evon A Bolessa

This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Merck + Co., Inc.. Active years: 1995-1996.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Evon A Bolessa. Retrieved from https://idiyas.com/inventor/evon-a-bolessa

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

 

Average Co-Inventor Count = 14.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 1995-1996

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Discovering the Innovations of Evon A. Bolessa

Introduction

Evon A. Bolessa, a prominent inventor based in Edison, NJ, has made significant contributions to the field of anti-fungal agents. With a total of two patents to his name, he exemplifies the spirit of innovation that drives advancements in medicine and agriculture.

Latest Patents

Bolessa's latest patents focus on anti-fungal agents featuring a specific compound formula. Each patent outlines a compound described as an effective anti-fungal agent derived from the producing organism Colletotricum acutatum. The method of production is also elaborated upon, showcasing the practical applications of his discoveries in combating fungal diseases.

Career Highlights

Currently, Bolessa is associated with Merck & Company, Inc., a leading global healthcare company committed to innovation. His work at Merck emphasizes the development of new solutions in pharmaceutical sciences, particularly in the area of fungal disease treatment.

Collaborations

Throughout his career, Bolessa has collaborated with esteemed coworkers, including Robert E. Schwartz and Gerald F. Bills. These partnerships highlight the importance of teamwork in the inventive process, as diverse perspectives can lead to groundbreaking discoveries.

Conclusion

Evon A. Bolessa's contributions to the field of anti-fungal agents, coupled with his collaboration with industry experts, underscore his role as a vital innovator. As he continues his work at Merck & Company, Inc., he remains a figure to watch in the ongoing pursuit of effective treatments in the healthcare sector.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…